Indo Rama Synthetics (India) Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/83g3uiiwbmivfa8n9pqjessz.pdf

Key Takeaways


Profitability & Margin Drivers

Lohia: "Unless the double-digit margins will be there, nobody is going to invest. So margin has to go up for new investment to come."

Industry Structure & Competitive Shift

Lohia: "China is gradually is getting out of the commodity business and so the competition from China is not much there and because the currency devaluation in the last one and a half years, where compared to Chinese yuan, which was INR12 early '25, today is INR14.5. So Chinese competition is getting away and going forward, I do not see much Chinese competition and our margin may be maintained."

Volume & Utilization


Exports & Trade Agreements


Domestic PTA & Raw Material Integration


Specialty Expansion & Capex


Guidance & Commitments

CommitmentSpecificsTimeline
Full-year EBITDAINR400 crores plus (H1 already INR225 crores)FY27
Full-year turnoverWill exceed last year's turnover despite low Q1FY27
Full-year volumeAround 4 lakh tonnes (down from 4.75 lakh tonnes in FY26)FY27
Volume recoveryBack to 4.75 lakh tonnes plusFY28
EBITDA margin9.9% H1 margin maintained; no big change seenNext two quarters
Specialty expansion commercial operationsWithin Calendar Year 2027CY2027
Specialty expansion incremental EBITDAINR100 croresFY28-29
PET chip utilizationRamp up from 60% toward 100% graduallyNo date (underway)
Export share recoveryTarget 20% to 25%Conditional on domestic PTA availability and trade agreements
Domestic PTA margin benefit2% to 3% gain from reduced importsWhen domestic PTA becomes available (2027-28)

Key Metrics

MetricQ2 FY27
Total income₹1,344 cr, +10% YoY from ₹1,222 cr
EBITDA₹117.7 cr, +46.4% YoY from ₹80.4 cr
EBITDA margin8.8%, expanded 220 bps YoY from 6.6%
Profit after tax₹74.1 cr, +201.8% YoY from ₹24.6 cr
PAT margin5.5%, up from 2% YoY
Finance cost₹29 cr, down from ₹33.6 cr YoY
H1 FY27 total income₹2,284 cr, down 9.7% YoY from ₹2,531 cr
H1 FY27 EBITDA₹225.7 cr, +24.9% YoY from ₹180.7 cr
H1 FY27 EBITDA margin9.9%, expanded 280 bps YoY from 7.1%
H1 FY27 PAT₹137.8 cr, +78.3% YoY from ₹77.3 cr
H1 FY27 operating cash flow₹328.5 cr, vs approx. ₹92 cr in H1 FY26
Net debt~₹852 cr as of Sep 30, 2026, down 23.5% from ₹1,113 cr at FY26-end
Debt-to-equity1.31x, improved from 2.18x at FY26-end
Trailing 12-month ROE38.2%, vs 33.85% at FY26-end
Trailing 12-month ROCE27%, vs 20.34% at FY26-end
Capacity utilization (FY26)68%, vs 58% in FY25
FY27 volume expectation~4 lakh tonnes, vs ~4.75 lakh tonnes in FY26
Exports share of revenue5.59%, down from 20–25% historically
Specialty expansion capex approved~₹200 cr, across company and subsidiary; commercial ops expected CY2027
Expected top-line growth from capex~15%, with ~20% EBITDA growth, payback under 2 years
FY27 full-year EBITDA expectation₹400 cr plus, vs H1 FY27 EBITDA of ₹225.7 cr
PET chip plant utilization60%, while filament and fiber lines at 100%
Raw material price increase (last half)40–45%, passed on to customers with a lag of a week to 10 days
Crude price$115 per barrel
Chinese yuan vs INR₹14.5, vs ₹12 in early 2025